c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US6794151B2 · kind B2 · utility
58Cited by
0References
6Claims
0Family size
Inventor
Key dates
| Filing date | Jun 4, 2001 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Jul 18, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57438
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method of diagnosing the presence or absence of cancer in a human patient is disclosed. In one embodiment, this method comprises the steps of examining patient tissue for the CRD-BP expression levels and comparing that expression level with control levels. The present invention is also a method of inhibiting cancer cell growth comprising the step of eliminating or lowering the level of functional CRD-BP in the cancerous tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.